9100 SOUTH HILLS BLVD, SUITE 300, BROADVIEW HEIGHTS, OH
Sotera Health Company Underwriting Agreement for 25 Million Shares
Delivers 20th Consecutive Year of Revenue Growth and Provides 2026 Outlook
Board Expansion; Richard G. Kyle Appointed as Class III Director
To Showcase Continued Revenue Growth and Strategic Value Creation at 44th Annual J.P. Morgan Healthcare Conference
Sotera Health Company Enters Underwriting Agreement for 30 Million Shares
Reports Strong Third-Quarter and Year-to-Date 2025 Results
News, Material Contracts
News, Underwriting Agreement, Legal Opinion
FY 2024
Q3
Q2
Q1
S-3ASR
Prospectus filed pursuant to Rule 424(b)(4)
Effectiveness Notice
S-1
Direct Registration System
Registration Statement for Securities to be Offered to Employees
Certificate
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership
Amended Schedule 13G - Ownership Report
Initial Statement of Beneficial Ownership
Prospectus filed pursuant to Rule 424(b)(7)